Cargando…
Recent Advances in Treatment Options for Childhood Acute Lymphoblastic Leukemia
SIMPLE SUMMARY: Acute lymphoblastic leukemia is the most common blood cancer in pediatric patients. Despite the enormous progress in ALL treatment, which is reflected by a high 5-year overall survival rate that reaches up to 96% in the most recent studies, there are still patients that cannot be sav...
Autores principales: | Malczewska, Marta, Kośmider, Kamil, Bednarz, Kinga, Ostapińska, Katarzyna, Lejman, Monika, Zawitkowska, Joanna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9032060/ https://www.ncbi.nlm.nih.gov/pubmed/35454927 http://dx.doi.org/10.3390/cancers14082021 |
Ejemplares similares
-
Targeted Therapy in the Treatment of Pediatric Acute Lymphoblastic Leukemia—Therapy and Toxicity Mechanisms
por: Lejman, Monika, et al.
Publicado: (2021) -
Overcoming Steroid Resistance in Pediatric Acute Lymphoblastic Leukemia—The State-of-the-Art Knowledge and Future Prospects
por: Kośmider, Kamil, et al.
Publicado: (2022) -
Overview on Aneuploidy in Childhood B-Cell Acute Lymphoblastic Leukemia
por: Panuciak, Kinga, et al.
Publicado: (2023) -
Genomic Analyses of Pediatric Acute Lymphoblastic Leukemia Ph+ and Ph-Like—Recent Progress in Treatment
por: Kaczmarska, Agnieszka, et al.
Publicado: (2021) -
The New Therapeutic Strategies in Pediatric T-Cell Acute Lymphoblastic Leukemia
por: Lato, Marta Weronika, et al.
Publicado: (2021)